Anderson Hoagland & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,610
| Closed | -$1.8M | – | 89 |
|
|
2019
Q3 | $1.8M | Buy |
18,610
+6,034
| +48% | +$573K | 1.09% | 24 |
|
|
2019
Q2 | $1.18M | Sell |
12,576
-3,724
| -23% | -$354K | 0.73% | 42 |
|
|
2019
Q1 | $1.44M | Buy |
16,300
+559
| +4% | +$48.9K | 0.87% | 35 |
|
|
2018
Q4 | $1.02M | Buy |
15,741
+440
| +3% | +$32.5K | 0.72% | 43 |
|
|
2018
Q3 | $1.39M | Buy |
15,301
+551
| +4% | +$48.7K | 0.78% | 39 |
|
|
2018
Q2 | $1.17M | Sell |
14,750
-32
| -0.2% | -$2.66K | 0.65% | 50 |
|
|
2018
Q1 | $1.32M | Buy |
14,782
+55
| +0.4% | +$5.28K | 0.76% | 43 |
|
|
2017
Q4 | $1.54M | Sell |
14,727
-660
| -4% | -$74.5K | 0.9% | 38 |
|
|
2017
Q3 | $2.24M | Buy |
15,387
+343
| +2% | +$46.7K | 1.38% | 22 |
|
|
2017
Q2 | $1.95M | Buy |
15,044
+2,754
| +22% | +$337K | 1.25% | 27 |
|
|
2017
Q1 | $1.53M | Hold |
12,290
| – | – | 0.82% | 50 |
|
|
2016
Q4 | $1.42M | Buy |
12,290
+40
| +0.3% | +$4.46K | 0.83% | 47 |
|
|
2016
Q3 | $1.28M | Hold |
12,250
| – | – | 0.73% | 51 |
|
|
2016
Q2 | $1.21M | Hold |
12,250
| – | – | 0.74% | 48 |
|
|
2016
Q1 | $1.23M | Buy |
12,250
+2,500
| +26% | +$257K | 0.76% | 43 |
|
|
2015
Q4 | $1.17M | Hold |
9,750
| – | – | 0.72% | 44 |
|
|
2015
Q3 | $1.05M | Hold |
9,750
| – | – | 0.67% | 45 |
|
|
2015
Q2 | $1.13M | Hold |
9,750
| – | – | 0.66% | 48 |
|
|
2015
Q1 | $1.05M | Hold |
9,750
| – | – | 0.61% | 45 |
|
|
2014
Q4 | $1.09M | Hold |
9,750
| – | – | 0.66% | 43 |
|
|
2014
Q3 | $926K | Buy |
9,750
+4,875
| +100% | +$440K | 0.57% | 48 |
|
|
2014
Q2 | $419K | Sell |
4,875
-4,875
| -50% | -$371K | 0.27% | 89 |
|
|
2014
Q1 | $681K | Hold |
9,750
| – | – | 0.45% | 54 |
|
|
2013
Q4 | $824K | Hold |
9,750
| – | – | 0.57% | 47 |
|
|
2013
Q3 | $751K | Buy |
+9,750
| New | +$683K | 0.52% | 48 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Anderson Hoagland & Co's CELG Position: Q4 2019 in Review
Anderson Hoagland & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 18,610 shares — an estimated $1.8M sold.
Anderson Hoagland & Co first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $2.24M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Anderson Hoagland & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Anderson Hoagland & Co sold 18,610 Celgene Corp shares in Q4 2019, an estimated $1.8M.
- Anderson Hoagland & Co first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
- Anderson Hoagland & Co's Celgene Corp position peaked at $2.24M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Anderson Hoagland & Co's 13F filing for Q4 2019, filed 6 Jan 2020.